Annual Drug Patent Expirations for FINACEA Finacea is a drug marketed by Leo Pharma As and is included in two NDAs. It is available from three suppliers. There are eight…
The post New patent expiration for Leo Pharma drug FINACEA appeared first on Drug…
New patent expiration for Leo Pharma drug FINACEA Read Post »
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. There are four…
The post New patent expiration for Mylan Speciality drug DYMISTA appeared first…
New patent expiration for Mylan Speciality drug DYMISTA Read Post »
DYMISTA (azelastine hydrochloride; fluticasone propionate) Mylan speciality lp Patent: 8,163,723 Expiration: Feb 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Pate…
Drug Patent Expirations for the Week of February 25, 2024 Read Post »
Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for Almatica drug GRALISE appeared first on …
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.…
The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on Dru…
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Baudax drug ANJESO appeared first on …
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first on D…
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Boehringer Ingelheim drug OFEV appeared fi…
New patent expiration for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for ZOLINZA Zolinza is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Msd Sub drug ZOLINZA appeared first on DrugPatentWa…
AURYXIA (ferric citrate) Keryx biopharms Patent: 9,050,316 Expiration: Feb 18, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug P…
Drug Patent Expirations for the Week of February 18, 2024 Read Post »